Reprotech LTD
 

TopFertility Preservation Network e-News  

October, 2012   Like us on Facebook  Follow us on Twitter View our videos on YouTube

In This Issue
FDA Issues Cease Operations
FDA Compliance
Free Fertility Drugs for Cancer Patients
RTL Oncology Presentations
Breast Cancer Survivor
Where in the World is RTL?
Industry News

ReproTech

Now Open

in Texas!

 Texas Flyer  

October is National Breast Cancer Awareness Month

 Susan G. Komen launches

"31 Days of Impact"

Verna's Purse

ReproTech's

Financial Assistance Program for Cancer Patients' Tissue Storage

 Verna's Purse Logo NEW

 www.vernaspurse.org

 

Thank you for your referrals.  We have approved 176 patients over the past 12 months!

 

 Check out our
YouTube videos!

Hurricane Video
Hurricane Storm Shelter
FL Storm Shelter
RTL-FL's
Storm Shelter

Fertility Preservation:

There's an App for that!

  

 Look out for

Version 2.0,

available this week!

 FDA Issues Order to Cease Operations of HCT/P's

   

The FDA issued an order to Cease Operations of HCT/P's to a Florida fertility center in September.

 

Click here to view the letter on the FDA's Orders and Public Notifications Page.

 

Reglera Can Help with FDA Compliance,

including Donor Eligibility

 

Thanks to everyone who attended Reglera's Reproductive Compliance Conference in Golden, CO last month.  With the speakers providing a wealth of crucial information on FDA regulations, including case studies, the conference was a great success.

 

During the conference Reglera provided a brief overview of its

Donor Eligibility System.  Developed with ReproTech, the system is the first of its kind, an automated web accessible system to assist in the donor eligibility determination process. This system is specifically designed to provide tissue organizations with the ability to fully automate the donor eligibility process in a way that is not only compliant with FDA 21 CFR 1271, but also speeds up eligibility determination and saves money.

 

Reglera is scheduling demonstrations of its Donor Eligibility System during ASRM at its booth #1233, and invites you to schedule a time to stop by to take a look.  Please contact Cindy at Reglera at blincic@reglera.com to schedule a time that works for you. 

 

 Walgreens/Ferring Providing Free Fertility Drugs

and Resources to Cancer Patients

 

Walgreens and Ferring Pharmaceuticals Inc. are collaborating to provide free access to certain fertility medications and educational resources as part of Ferring's h.e.a.r.t. BEAT program. The medications covered by the program are Bravelle, Menopur, and Novarel. Resources provided include informational guides detailing how cancer treatment affects fertility, access to highly specialized nurses, multimedia materials outlining potential fertility options patients may wish to discuss with their physician, and specialized modules to teach injection training.
 

ALL CANCER PATIENTS QUALIFY!

 

Call Walgreens Specialty Pharmacy at

888-347-3415 with any questions.

 

Click here for more information.

 

RTL Staff Discuss Fertility Preservation at Oncology Conferences

 

ReproTech staff were excited to speak at two local Oncology events in September.

 

RTL-MN site director, Jill, and FPN doc, Randle Corfman, Ph.D., M.D., of the Midwest Center for Reproductive Health presented at at CentraCare's Oncology Conference in St. Cloud, MN.

 

RTL-FL site director, Heather, and FPN doc, Jenna McCarthy, M.D., of South Florida Institute for Reproductive Medicine, presented at the Space Coast ONS Chapter's "Oncology Potpourri" in Melbourne, FL.

 

RTL-TX Site Director's Sister Featured in Breast Cancer Survivor Article

 

With October being Breast Cancer Awareness Month, we thought we'd share the inspiring story of the sister of Nanette, RTL-Texas' site director. Kathleen is now a six year survivor of breast cancer doing very well, and her family history and story show just how much she has endured and fought to overcome this disease. Kathleen and Nanette have lost their grandmother, father and sister, all to breast cancer.

 

Read Kathleen's story

 

globe2012   

    Where in the

    World is ReproTech?

  

September and October are busy months for ReproTech, and we want to thank everyone who visited our booth or spoke with us at the Southwest Fertility Forum in Austin, at the AATB meeting in Keystone, at Reglera's Reproductive Compliance Conference in Golden and at the Oncofertility Conference in Chicago.  If you missed us, please stop by our booth at ASRM, where you can register to win an iPad!

 

September's Academy of Oncology Nurse Navigators' (AONN) Third Annual Conference in Phoenix was a great success for ReproTech.  Edie and Joy exhibited and were able to provide education on Fertility Preservation and our FPN members to many amazing nurses and other oncology professionals.   

 

Joy and Russ will be exhibiting at the National Coalition of Oncology Nurse Navigators' (NCONN) Fourth Annual Conference in Nashville, TN

on October 4 - 6.

 

American Society for Reproductive Medicine (ASRM) Annual Meeting

in San Diego, CA on October 20 - 24: Stop by ReproTech's booth #1226 where you can

Register to win an iPad! iPad

 

Jill, Danika, Joy, Russ & Brent look forward to seeing you!

 

Industry News

 

First Mother-to-Daughter Uterine Transplants Offer Fertility Hope for Cancer Survivors

 

Stem Cells Translational Medicine Article:

Fertility Preservation:  An Update  

 

Alarming Breast Cancer Rates Among Troops 

 

Senate Panel OKs Veterans Infertility Bill

 

Springer Abstract:  Addressing the Three Most Frequently Asked Questions of a Bioethisist in an Oncofertility Setting

 

Article featuring Oncofertility Consortium docs:

Preserving Fertility in Childhood Cancer Patients

 

New method Increases viability of frozen embryos, expands reproductive options 

 

Correction to the numbers in recent Washington Post article:

Future of Frozen Embryos

 

Article featuring our Florida FPN members:

Frozen egg donor banks sprout in wake of new technology

  

MN 888-489-8944 * FL 888-953-9669

NV 888-831-2765 * TX 888-350-3247

 

Back to Top